Tag: Pop
News alerts
Latest content
- UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention

- Saphnelo approved in the US for subcutaneous self‑administration

- Transgene completes randomisation in phase 2 trial of tg4050

- Bayer wins MHRA approval for Kerendia in heart failure

- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
